Below are resources and work our member organizations are doing to address drug shortages.
RISCS Predictiveness and Utility of the RISC Rating System™ in Identifying Supply Chain Risks and Preventing Drug Shortages
The RISC Rating System™ evaluates the resilience of pharmaceutical supply chains and helps drug purchasers to identify the manufacturers that are investing in their supply chains.
Vizient Evaluating the Impact of the Oncology Drug Shortage
This paper analyzes the current suppliers and market conditions for each of these seven oncology drugs and the factors contributing to their shortage status in the U.S.
Vizient & RISCS Pilot Program to Improve Pharmaceutical Supply Chain Resilience
A joint pilot program aimed at enhancing assurance of pharmaceutical supply. Once implemented, the program would use a rating system to enable the evaluation of critical aspects of a resilient supply chain and provide increased transparency.
Vizient & CHA Pediatric Drug Shortage Trends and Best Practices for Mitigation Strategies
A report examining the impact of drug shortages on self-governed pediatric hospitals, and the strategies employed to manage and mitigate these shortages.
A 90-day pilot program provides pediatric hospitals with over 140,000 essential medicine treatments and paves the way for a more resilient supply chain for our most vulnerable patients.
ASHP Severity and Impact of Current Drug Shortages
The survey results include responses from 1,123 participants who answered at least part of the online questionnaire. The survey was conducted from June 23 through July 14, 2023.
The goal of Project PROTECT is to partner with the pharmaceutical supply chain to protect essential medicines vulnerable to drug shortage. The project aims to bolster the supply chain by increasing production of vulnerable medicine during times of shortage.
The RISC Rating System is an independent, standardized rating/certification process that uses manufacturer-reported data to compare supply chain sustainability at the NDC level.
Vizient Drug Shortages and Labor Costs - Measuring a Hidden Cost of Drug Shortages on U.S. Hospitals
Between March 6 and April 4, 2019, the Vizient® Drug Shortages Task Force conducted its inaugural member survey, to identify and quantify the labor-related operational and financial impact of drug shortages on member health systems and hospitals.
